23 Stock Top Picks and 5 ETF (Feb 01-07)

(A Top Pick Oct 25/19, Down 3%) Theme parks and cruises brought it down. They have no revenue streams from these but it is almost what it was before the pandemic. They pushed more content through their Disney Plus. He would continue to buy it on dips.

The gold standard in the industry. They have the best products, sales force and are quick to adapt. They are very innovative. As surgeries start to pick up, their products will see more demand. They are expected to earn $10/share. They are trading at a cheap multiple to normalized earnings. (Analysts’ price target is $214.35)

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The stock has shown some weakness recently, but there has been no negative news. The stock is still up year to date and ahead of the tsx average. Unlock Premium - Try 5i Free

Low mortgage rates and a want to move to less dense housing has been a tailwind for home builders. Financing is quite cheap and there is a real issue with supply. Demand outstrips supply. (Analysts’ price target is $87.78)

HD vs. Lowes He's come close to buying HD in the past. It pays a 2.1% yield vs. Lowes' 1.3%, and HD boasts better metrics elsewhere. Key point it that scale matters in this business, and the 3x bigger HD enjoys a size advantage and has a wider moat (can get better pricing and service…

Bad news is outside margin pressure in US. Dividend is great, not going away. Terrific balance sheet. Earnings were in line last quarter. Pretty good valuation. Expensive relative to its peers, but exceptionally well run. We're at the bottom of the cycle. Concern is credit. With a better economy, should do very well.

(A Top Pick Aug 02/19, Up 22%) A defensive, not a cyclical, stock. Okay to own now, but as we exit this recession (this shortest ever), it's better to own cyclicals. They're an auto insurer and diversifying into commercial. They have a low cost base, a tailwind, and are diversified nationally in the U.S. But…

He prefers buying a insurance company directly like Manulife and Intact. Though well-run, FFH has a mixed bag of many assets. This mix adds a level of risk vs. pure insurers.

We've seen the bounce from March 23, but they haven't performed well since then. There's lack of visibility on the future. Until we get past Covid, it's not his favourite sector. It has structural headwinds against it. People are out of work, and we haven't had the wave of bankruptcies yet. Better places to look.

50,000 apartment units, many in the GTA. You are going to have immigration come back into Canada early next year after a vaccine starts to get used. They are collecting 99% of their rents right now. It is a blue chip REIT here in Canada that looks miss-priced. (Analysts’ price target is $55.60)

CNR-T vs. CP-T. It has always been a coin flip. He has always chosen CNR-T. You can't go wrong with either of them and they both continue to raise their dividends. He owns more CNR-T than CP-T.

(A Top Pick Sep 30/19, Up 16%) There is still good opportunities in the engineering consulting side. There is potential large spending in infrastructure. The model average return is 26%.

Wonderful promise, you just need patience. Held back because of commercial aerospace exposure. Longer term, as things start to normalize, this company has lots of legs. Ton of free cash flow, which should get back to the shareholder and further bolster the price.

CNR-T vs. CP-T. It has always been a coin flip. He has always chosen CNR-T. You can't go wrong with either of them and they both continue to raise their dividends. He owns more CNR-T than CP-T.

Need to be patient over next year or so. Lots of cash on hand, so they'll survive. Highly cyclical. Starting to inch its way up. Once we start to see normalcy in travel, could do very well. Small position only in this, and depends on your risk tolerance and time horizon.

Very interesting opportunity. Automating production in healthcare and battery production. World is looking to lower costs and bring some processes onshore. Backlog is growing. Right place at right time. Stock's unreasonably down 20% this year. Great management executing well. No dividend. (Analysts’ price target is $25.50)

A cloud-based mobile collaboration platform with a cybersecurity overlay. It trades at only 25x 2021 earnings. Activist investors were agitating for change until they reached an agreement with Box's managers. Since March, both sides have bolstered margins and growth. Thes tock is up 70% since April. Tomorrow, it unveils new products and services. Overlooked by…

(A Top Pick Nov 13/19, Up 23%) One of the top beneficiaries of digital advertising. Also has so many revenue streams not linked to advertising. Doesn't seem to be impacted by the DoJ anti-trust announcement. Very decent margins. Price target of $1,760.

(A Top Pick Sep 10/19, Down 17%) They got hurt late 2019 because of delayed capex by the US telcos like AT&T. But they are now spending on the 5G network. Has large exposure to Asia, sot hey got hit hard in Q1. Business though is recovering in cell phones in Asia and elsewhere, and…

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. A cloud-based subscription software for supply chain operation. It has a great balance sheet with high growth potential. Global growth is also a possibility. Unlock Premium - Try 5i Free

Several big tech names report next week, but he expects this to be a winner. It popped today. FB is led by Instagram Shops, a brilliant idea to help small businesses operate online.

They developed a cloud computing platform to help companies with digital operations. Founded in 2003, it IPO's in 2012 and has since acquired several good companies. He particularly likes that 90% of their revenue is recurring. This reduces the risk. Although a little pricey at 15 times revenues. He would look to buy around $325.…

If Biden wins Will benefit if Biden wins. China has already granted MA approval to start a new operation in China, but the trade war bogged down progress. Biden will lower the tension between US and China and this will benefit Mastercard.

It's a good place to start, low-cost and liquid. Long-term this is set up for a good return. But this is very broad-based, overweighting the winners of recent years. He prefers specific

Brazil is the one country with a growing PMI. This economy could do very well.

It specializes in medical devices and equipment. He has held this over a year and a half. He likes the diversification it offers. He is not sure which of the holdings are involved in manufacturing defibrillators.

Not yet. Investors can re-balance their portfolios. If you aimed for one percentage of equities and another for bonds, you can move money to maintain that balance. That is one of the most prudent things people can do. The bottoms are not in yet.

(A Top Pick Jan 07/19, Up 14%) They are one of the lead orders on this. There was a technical issue where it was listed on the TSX and NEO. The fund refused to list it on the TSX. It doesn't have good liquidity due to this and so they gave it up.